Why Uttarakhand
SIDCUL Bahadrabad offers established pharma infrastructure, skilled workforce and connectivity to North India distribution networks.
Corporate office Ahmedabad — manufacturing at Haridwar (Unit-1) and Kathua, J&K (Unit-2). ₹125 crore combined investment.
Corporate office of Sucantis Biotech for enquiries and partner coordination.
Flagship WHO-GMP certified facility with dedicated beta-lactam, cephalosporin and general formulation blocks. License obtained November 2023.
Second manufacturing unit to expand beta-lactam and cephalosporin capacity. License obtained May 2025.
Strategic expansion supporting growing domestic CDMO demand and export programmes for beta-lactam and cephalosporin formulations.
Ghatti, District Kathua,SIDCUL Bahadrabad offers established pharma infrastructure, skilled workforce and connectivity to North India distribution networks.
Haridwar and Kathua provide redundant capacity and geographic flexibility for domestic and export supply programmes.
Plant visits for serious manufacturing partners. Write to info@sucantis.com with preferred dates.
Our team will coordinate directions, visit slots and commercial enquiries.
Contact Us